Table 3.
Multi-drug resistant bacteria as the etiological factor of infections.
| MRSA (among All S. aureus Cases) | VRE E. faecium (among All E. faecium Cases) | VRE E. faecalis (among All E. faecalis Cases) | ESBL E. coli (among All E. coli Cases) | AmpC E. coli (among All E. coli Cases) | ESBL Klebsiella (among All Klebsiella Cases) | MBL Klebsiella (among All Klebsiella Cases) | ESBL Enterobacter (among All Enterobacter Cases) | MDR Acinetobacter Spp. | MDR P. aeruginosa (among All P. aeruginosa Cases) | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total number of cases | 262 | 184 | 69 | 359 | 14 | 418 | 100 | 67 | 250 | 60 |
| The incidence of infections * | 0.17% | 0.12% | 0.05% | 0.24% | 0.01% | 0.28% | 0.07% | 0.04% | 0.17% | 0.04% |
| Percentage of hospital-acquired infections ** (n) | 72.9% (191) | 77.7% (143) | 79.7% (55) | 40.4% (145) | 28.6% (4) | 60.3% (252) | 81.0% (81) | 74.6% (50) | 85.6% (214) | 66.7% (40) |
| Rate of hospital-acquired to non-hospital-acquired infections | 2.69 | 3.49 | 3.93 | 0.68 | 0.40 | 1.52 | 4.26 | 2.94 | 5.94 | 2.00 |
* Percentage of patients diagnosed with MDR bacterial infections among all hospitalized patients. ** Cases diagnosed after >72 h of hospitalization. AmpC—bacteria producing AmpC-type beta-lactamases; ESBL—bacteria producing extended-spectrum beta-lactamases; MBL—bacteria producing metallo-beta-lactamase; MDR—multidrug resistant bacteria; MRSA—methicyllin-resistant Staphylococcus aureus; VRE—vancomycin-resistant Enterococcus.